Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Johnson & Johnson (JNJ) News - StockMarketCap

Stocks›Johnson & Johnson☆

● At closeAs of Jul 2, 2026

Johnson & Johnson

JNJ✓

HealthcareDrug Manufacturers - GeneralNYSE

$263.04+3.57%

$633.20BMarket cap

29.29xP/E ratio

7.90MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$263.04

$9.06 (+3.57%) · 24h

Key metrics

Market cap$633.20B+13.63%

Enterprise value$644.66B

Volume (24h)7.90M

P/E ratio (TTM)29.29x

P/S ratio (TTM)6.34x

Dividend yield2.06%

Shares outstanding2.41B

Trading range

Previous close$253.98

Day range$254.00 - $263.09

52-week range$152.81 - $259.88

Johnson & Johnson (JNJ) operates in the Drug Manufacturers - General industry within the Healthcare sector, listed on NYSE.

Similar stocks

Eli Lilly and Company+1.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Novartis AG+2.42%

Latest news